Gilead Sciences vs Doximity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Doximity leads in AI visibility (86 vs 78)
Gilead Sciences logo

Gilead Sciences

LeaderHealthcare Tech

Enterprise

Antiviral biopharma with $28.6B FY2024 revenue; Biktarvy $14B HIV franchise; lenacapavir 99%+ HIV prevention efficacy in 2024 trials is landmark breakthrough; Trodelvy oncology expansion.

AI VisibilityBeta
Overall Score
B78
Category Rank
#37 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
80
Gemini
81

About

Gilead Sciences is a biopharmaceutical company specializing in antiviral medicines, oncology, and inflammatory diseases, founded in 1987 and headquartered in Foster City, California, trading on Nasdaq (GILD). The company reported approximately $28.6 billion in total revenues for FY2024 under CEO Daniel O'Day, driven by the world's leading HIV treatment franchise anchored by Biktarvy—the world's best-selling antiretroviral therapy with over $14 billion in annual global sales—along with Veklury (remdesivir) for COVID-19 treatment, and a growing oncology portfolio including Trodelvy (sacituzumab govitecan, an ADC for breast and bladder cancer), Yescarta, and Tecartus (CAR-T cell therapies). Gilead's 2024 HIV prevention breakthrough—lenacapavir, a twice-yearly injection preventing HIV infection with near-100% efficacy in large clinical trials—represents potentially the most important HIV prevention advance since the development of daily oral PrEP.

Full profile
Doximity logo

Doximity

GrowthHealthTech

Physician Professional Network

Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.

AI VisibilityBeta
Overall Score
A86
Category Rank
#6 of 596
AI Consensus
85%
Trend
stable
Per Platform
ChatGPT
85
Perplexity
84
Gemini
88

About

Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.

Full profile

AI Visibility Head-to-Head

78
Overall Score
86
#37
Category Rank
#6
81
AI Consensus
85
stable
Trend
stable
79
ChatGPT
85
80
Perplexity
84
81
Gemini
88
75
Claude
81
74
Grok
85

Key Details

Category
Enterprise
Physician Professional Network
Tier
Leader
Growth
Entity Type
company
brand

Capabilities & Ecosystem

Capabilities

Only Doximity
Physician Professional Network

Integrations

Only Gilead Sciences
Gilead Sciences is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.